Latest Whitepapers
Whitepaper
Streamlining Affinity Analysis for Accelerated Drug Discovery
This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening.
Whitepaper
Diving Deep Into Cell Therapy: An Industry Perspective
Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Whitepaper
Enhance the Cost-Effectiveness of Your cGMP Chemical Supply Chain
Chemical supply chain issues can have real, quantifiable impacts on biomanufacturers. While the efficient management of storage and inventory can help to reduce risk, it can also prove resource intensive and increase the total cost of ownership.
Whitepaper
Genetic Insights for Biopharmaceuticals: Propelling Drug Candidates into Therapeutic Assets
Innovation is key for any biopharmaceutical and biotechnology company. Whilst the demand for infectious disease prevention continues to grow, so does the pressure on these companies to deliver innovative solutions.
Whitepaper
Fast, Sensitive and Robust Host Cell Protein Analysis
Process development teams need detailed information, via a platform that delivers short gradients to allow the required sample throughput to detect HCPs in a low sub-ppm range.
Whitepaper
Updated Air Monitoring Requirements for Medical Device Manufacturers
The EU GMP Annex 1 provides specific guidance on the manufacture of sterile medicinal products. Though it is a European guide for manufacturing, EU GMP Annex 1’s impact is global. So how does the latest revision affect you?
Whitepaper
Expanding the Animal Genomics Wheelhouse With CRISPR/Cas9
CRISPR/Cas9 has revolutionized the field of genome editing by increasing the efficiency, multiplex capability and ease of use like never before.
Whitepaper
Top Five Considerations When Making Decisions for a More Robust Harvest
Download this whitepaper to explore considerations when selecting a harvest technology such as sustainability, time and cost as well as space and scale.
Whitepaper
How To Protect Frozen Patient Samples in the Event of a Freezer Malfunction
In 2012, the Harvard Brain Tissue Resource Center lost 150 of its stored frozen brain samples, including one third of the world’s largest collection of autism brain tissue.
Whitepaper
Accelerating Drug Discovery With Real-Time Kinetic and Affinity Analysis
Bioassays, such as the enzyme-linked bioabsorbant assay (ELISA), are standard techniques that require enzyme or fluorescent labels for the detection of target analytes. While these label-based studies give important information about a sample, such as binding affinity, they can only measure the interaction of an analyte at a given concentration and time, and are unable to gather kinetic analysis.
Advertisement
